Anti-inflammatory effects of Arnica montana (mother tincture and homeopathic dilutions) in various cell models.


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
10 Jan 2024
Historique:
received: 28 06 2023
revised: 07 08 2023
accepted: 17 08 2023
medline: 18 9 2023
pubmed: 21 8 2023
entrez: 20 8 2023
Statut: ppublish

Résumé

The plant Arnica montana L. has been shown to alleviate inflammation, pain and swelling associated with trauma, and post-operative clinical conditions, yet the mechanism of action is not well understood. The study was designed to investigate the effect of Arnica montana (A. montana) mother tincture and homeopathic dilutions on inflammation markers, oxidative stress and cell migration in diverse cell culture models. We tested A. montana mother tincture and a range of homeopathic dilutions in different human and murine cell culture models to demonstrate their anti-inflammatory properties by measuring the inflammatory markers: tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), cyclooxygenase-2 (COX-2), monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule (ICAM-1), reactive oxygen species (ROS) and cell migration. The inflammatory markers were measured by ELISA assays. The intracellular oxidative stress (ROS) in microglial cells was measured using Deep Red CellROX probe. The cell migration was examined by wound healing using the Oris Cell migration assay. These data showed the ability of A. montana (mother tincture and mainly 1C dilution) to significantly reduce TNFα production in inflamed macrophages compared with vehicle (control). They significantly reduced both IL-6 and MCP-1 in inflamed human microglial cells and significantly decreased COX-2 expression in inflamed murine fibroblasts. Moreover, A. montana mother tincture reduced the cell migration whereas 9C dilution significantly enhanced the migration of fibroblast cells compared with vehicle. The expression of ICAM-1 was significantly reduced with A. montana mother tincture and 1C, 3C, 5C, and 9C dilutions in inflamed human endothelial cells compared with vehicle. A. montana mother tincture and 1C, 3C, 5C and 9C dilutions induced a significant and consistent effect on ROS production in inflamed murine microglial cells. A. montana 1C had the largest impact on ROS production. Mother tincture and 1C dilution of A. montana showed anti-inflammatory properties assessed by measurement of several markers (pro-inflammatory cytokines, adhesion molecule, ROS) in various human and murine cell models. In addition, A. montana 3C, 5C, 9C dilutions have anti-inflammatory and antioxidant effects as highlighted on both primary endothelial cells and murine microglial cells.

Identifiants

pubmed: 37598770
pii: S0378-8741(23)00932-7
doi: 10.1016/j.jep.2023.117064
pii:
doi:

Substances chimiques

Cyclooxygenase 2 EC 1.14.99.1
Intercellular Adhesion Molecule-1 126547-89-5
Interleukin-6 0
Reactive Oxygen Species 0
Tumor Necrosis Factor-alpha 0
Plant Extracts 0
Biological Products 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117064

Informations de copyright

Copyright © 2023 Laboratoires Boiron SA. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this paper. At the time of the study, all the authors were employees of Laboratoires Boiron France-Messimy, pharmaceutical company producing homeopathic medicines. This professional relationship does not imply any misconduct on the part of the authors.

Auteurs

Justine Verre (J)

Laboratoires BOIRON, Research Department, 2 Avenue de l'Ouest Lyonnais, 69510, Messimy, France. Electronic address: justine.verre@boiron.fr.

Marie Boisson (M)

Laboratoires BOIRON, Research Department, 2 Avenue de l'Ouest Lyonnais, 69510, Messimy, France. Electronic address: marie.boisson@boiron.fr.

Anne Paumier (A)

Laboratoires BOIRON, Research Department, 2 Avenue de l'Ouest Lyonnais, 69510, Messimy, France. Electronic address: anne.paumier@boiron.fr.

Sandra Tribolo (S)

Laboratoires BOIRON, Research Department, 2 Avenue de l'Ouest Lyonnais, 69510, Messimy, France. Electronic address: sandra.tribolo@boiron.fr.

Naoual Boujedaini (N)

Laboratoires BOIRON, Research Department, 2 Avenue de l'Ouest Lyonnais, 69510, Messimy, France. Electronic address: naoual.boujedaini@gmail.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH